Page last updated: 2024-12-08

2-methylthio-n-6-isopentenyladenosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methylthio-N(6)-(Delta(2)-isopentenyl)adenosine : A nucleoside analogue in which adenosine has been modified by substitution at C-2 by a methylthio (methylsulfanyl) group and at the 6-amino nitrogen by a Delta(2)-isopentenyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID161337
CHEBI ID62875
SCHEMBL ID18171845
MeSH IDM0052406

Synonyms (29)

Synonym
adenosine, n-(3-methyl-2-butenyl)-2-(methylthio)-
20859-00-1
(2r,3s,4r,5r)-2-(hydroxymethyl)-5-[6-(3-methylbut-2-enylamino)-2-methylsulfanylpurin-9-yl]oxolane-3,4-diol
n(6)-(delta(2)-isopentenyl)-2-methylthioadenosine
n-(3-methylbut-2-en-1-yl)-2-(methylsulfanyl)adenosine
2-methylthio-n-6-isopentenyladenosine
2-methylthio-n(6)-(delta(2)-isopentenyl)adenosine
CHEBI:62875
2-methylthio-n(6)-isopentenyladenosine
2-mtia
ms2i6a
2-methyl-thio-n-6-isopentyladenosine
n-(3-methyl-2-butenyl)-2-(methylthio)adenosine
VZQXUWKZDSEQRR-SDBHATRESA-N
2-methylthio-n6-(.delta.2-isopentenyl)adenosine
2msa
n6-(.delta.2-isopentenyl)-2-methylthioadenosine
n6-isopentenyl-2-thiomethyladenosine
2-methylthio-n6-(.gamma.,.gamma.-dimethylallyl)adenosine
AKOS027324350
SCHEMBL18171845
2-methylthio-n6-dimethylallyladenosine
2-methylthio-n6-(delta2-isopentenyl)adenosine
n-(3-methylbut-2-en-1-yl)-2-(methylsulfanyl)-9-pentofuranosyl-9h-purin-6-amine
DTXSID30943113
Q27132248
(2r,3s,4r,5r)-2-(hydroxymethyl)-5-(6-((3-methylbut-2-en-1-yl)amino)-2-(methylthio)-9h-purin-9-yl)tetrahydrofuran-3,4-diol
ribosyl-2-methylthio-cis-zeatin
(2r,3s,4r,5r)-2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]-2-(methylsulfanyl)-9h-purin-9-yl}oxolane-3,4-diol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
nucleoside analogueAn analogue of a nucleoside, being an N-glycosyl compound in which the nitrogen-containing moiety is a modified nucleotide base. They are commonly used as antiviral products to prevent viral replication in infected cells.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (44.44)18.7374
1990's5 (27.78)18.2507
2000's0 (0.00)29.6817
2010's4 (22.22)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.40 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]